Slide Show: STD Awareness Month

At IDWeek 2026, Jimmy Chang, PhD, discussed investigational HIV antibodies TMB-365 and TMB-380, explaining their complementary mechanisms, early study findings, and ongoing evaluation as a long-acting maintenance regimen.

At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.

France’s first reported human Shamonda virus infection raises questions about transmission and vulnerable patients. Explore what investigators know, what remains uncertain, and why infection preventionists should follow this emerging story.

John Rex, MD, CMO of F2G, discusses investigational olorofim’s phase 3 findings, why new antifungals are difficult to develop, and how an oral option could help patients with limited treatment choices.

An analysis of 147 million US hospital admissions identified 875 adults with brucellosis diagnoses, highlighting demographic and regional differences while emphasizing exposure histories and uncertainty about underdiagnosis.

Kenya’s secondary Ebola cases raise urgent questions about hospital readiness. Explore what the response reveals about contact tracing, health care worker protection, and the implementation of infection prevention plans.

An ICU study found that alcohol-based hand rub applied after patient care reduced glove bioburden, while staff raised feasibility concerns. Researchers stress that the practice does not replace glove changes or hand hygiene.

A study of 4,851 nursing home residents linked shared rooms to higher odds of matching MDRO carriage, while universal decolonization was associated with lower concordant carriage across MRSA, ESBL, and VRE.